BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18466161)

  • 1. The effects of L-659,066, a peripheral alpha2-adrenoceptor antagonist, on dexmedetomidine-induced sedation and bradycardia in dogs.
    Honkavaara JM; Raekallio MR; Kuusela EK; Hyvärinen EA; Vainio OM
    Vet Anaesth Analg; 2008 Sep; 35(5):409-13. PubMed ID: 18466161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular and sedation reversal effects of intramuscular administration of atipamezole in dogs treated with medetomidine hydrochloride with or without the peripheral α
    Turunen H; Raekallio MR; Honkavaara JM; Restitutti F; Kallio-Kujala IJ; Adam M; Nevanperä K; Scheinin M; Männikkö SK; Hautajärvi HJ; Larenza Menzies P; Vainio OM
    Am J Vet Res; 2019 Oct; 80(10):912-922. PubMed ID: 31556714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of different doses of L-659'066 on the bispectral index and clinical sedation in dogs treated with dexmedetomidine.
    Restitutti F; Honkavaara JM; Raekallio MR; Kuusela EK; Vainio OM
    Vet Anaesth Analg; 2011 Sep; 38(5):415-22. PubMed ID: 21831046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of MK-467 on organ blood flow parameters detected by contrast-enhanced ultrasound in dogs treated with dexmedetomidine.
    Restitutti F; Laitinen MR; Raekallio MR; Vainionpää M; O'Brien RT; Kuusela E; Vainio OM
    Vet Anaesth Analg; 2013 Nov; 40(6):e48-56. PubMed ID: 23802592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of L-659,066, a peripheral α2-adrenoceptor antagonist, and verapamil on the cardiovascular influences of dexmedetomidine in conscious sheep.
    Raekallio MR; Honkavaara JM; Vainio OM
    J Vet Pharmacol Ther; 2010 Oct; 33(5):434-8. PubMed ID: 20840386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sedative and cardiorespiratory effects of acepromazine or atropine given before dexmedetomidine in dogs.
    Alvaides RK; Neto FJ; Aguiar AJ; Campagnol D; Steagall PV
    Vet Rec; 2008 Jun; 162(26):852-6. PubMed ID: 18587062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of MK-467 on sedation, heart rate and arterial blood pressure after intramuscular coadministration with dexmedetomidine in conscious cats.
    Honkavaara J; Pypendop B; Ilkiw J
    Vet Anaesth Analg; 2017 Jul; 44(4):811-822. PubMed ID: 28734853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between dexmedetomidine and a combination of medetomidine-vatinoxan on muscle tissue saturation in privately-owned adult dogs undergoing intradermal testing.
    McKenzie SR; Chiavaccini L; Moura RA; Santoro D
    Res Vet Sci; 2024 May; 171():105207. PubMed ID: 38460204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sedative effect of intramuscular medetomidine with and without vatinoxan (MK-467), and its reversal with atipamezole in sheep.
    Adam M; Raekallio MR; Vainio OM
    Vet Anaesth Analg; 2018 Nov; 45(6):788-793. PubMed ID: 30301665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dexmedetomidine and MK-467 on plasma glucose, insulin and glucagon in a glibenclamide-induced canine hypoglycaemia model.
    Kallio-Kujala IJ; Bennett RC; Raekallio MR; Yatkin E; Meierjohann A; Savontaus E; Scheinin M; Spillmann T; Vainio OM
    Vet J; 2018 Dec; 242():33-38. PubMed ID: 30503541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sedative and cardiovascular effects of intranasal or intramuscular dexmedetomidine in healthy dogs.
    Micieli F; Santangelo B; Reynaud F; Mirra A; Napoleone G; Della Valle G; Portier KG; Vesce G
    Vet Anaesth Analg; 2017 Jul; 44(4):703-709. PubMed ID: 28716686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of exercise-induced stress and dexamethasone on plasma hormone and glucose concentrations and sedation in dogs treated with dexmedetomidine.
    Raekallio MR; Kuusela EK; Lehtinen ME; Tykkyläinen MK; Huttunen P; Westerholm FC
    Am J Vet Res; 2005 Feb; 66(2):260-5. PubMed ID: 15757125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexmedetomidine low dose followed by constant rate infusion and antagonism by atipamezole in isoflurane-anesthetized cats: an echocardiographic study.
    Carvalho ER; Champion T; Ambrosini F; da Silva GA; Freitas GC; D'Otaviano de Castro Vilani RG
    Vet Anaesth Analg; 2019 Jan; 46(1):43-54. PubMed ID: 30420257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imidazoline 1 receptor activation preserves respiratory drive in spontaneously breathing newborn rats during dexmedetomidine administration.
    Sato N; Saiki C; Tamiya J; Imai T; Sunada K
    Paediatr Anaesth; 2017 May; 27(5):506-515. PubMed ID: 28177562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a peripheral site of action contributing to the voiding effects of α₂-adrenoceptor agonists and antagonists?
    Aro E; Bastman S; Andersson KE; Streng T
    World J Urol; 2015 Mar; 33(3):433-40. PubMed ID: 24903349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of the sedative and sympatholytic effects of dexmedetomidine with a specific alpha2-adrenoceptor antagonist atipamezole: a pharmacodynamic and kinetic study in healthy volunteers.
    Scheinin H; Aantaa R; Anttila M; Hakola P; Helminen A; Karhuvaara S
    Anesthesiology; 1998 Sep; 89(3):574-84. PubMed ID: 9743392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of MK-467, a peripherally acting α2-adrenoceptor antagonist on the disposition of intravenous dexmedetomidine in dogs.
    Honkavaara J; Restitutti F; Raekallio M; Salla K; Kuusela E; Ranta-Panula V; Rinne V; Vainio O; Scheinin M
    Drug Metab Dispos; 2012 Mar; 40(3):445-9. PubMed ID: 22112381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel alpha 2-adrenoceptor antagonist attenuates the early, but preserves the late cardiovascular effects of intravenous dexmedetomidine in conscious dogs.
    Pagel PS; Proctor LT; Devcic A; Hettrick DA; Kersten JR; Tessmer JP; Farber NE; Schmeling WT; Warltier DC
    J Cardiothorac Vasc Anesth; 1998 Aug; 12(4):429-34. PubMed ID: 9713732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiopulmonary and sedative effects of the peripheral α2-adrenoceptor antagonist MK 0467 administered intravenously or intramuscularly concurrently with medetomidine in dogs.
    Rolfe NG; Kerr CL; McDonell WN
    Am J Vet Res; 2012 May; 73(5):587-94. PubMed ID: 22533388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the sedative and cardiovascular effects of intramuscular administration of dexmedetomidine with and without concurrent atropine administration in dogs.
    Congdon JM; Marquez M; Niyom S; Boscan P
    J Am Vet Med Assoc; 2011 Jul; 239(1):81-9. PubMed ID: 21718200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.